 |
인쇄하기
취소
|
Kolon, Estech eye niche markets
Kolon Life Science and Estech Pharma are gearing up to increase investment in the biological and pharmaceutical ingredients business for more revenues.
Kolo says it has been developing a cell-mediated gene therapy “TissueGene-C“ to deliver a regenerative protein to a damaged tissue, which catalyzes rapid repair of injured cartilage without surgery. TissueGene-C mode of action is to increase ...
Kolo says it has been developing a cell-mediated gene therapy “TissueGene-C“ to deliver a regenerative protein to a damaged tissue, which catalyzes rapid repair of injured cartilage without surgery. TissueGene-C mode of action is to increase ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.